139 related articles for article (PubMed ID: 28076841)
1. Clonal evolution in therapy-related neoplasms.
Fabiani E; Falconi G; Fianchi L; Criscuolo M; Ottone T; Cicconi L; Hohaus S; Sica S; Postorino M; Neri A; Lionetti M; Leone G; Lo-Coco F; Voso MT
Oncotarget; 2017 Feb; 8(7):12031-12040. PubMed ID: 28076841
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
Shah MV; Mangaonkar AA; Begna KH; Alkhateeb HB; Greipp P; Nanaa A; Elliott MA; Hogan WJ; Litzow MR; McCullough K; Tefferi A; Gangat N; Patnaik MM; Al-Kali A; He R; Chen D
Blood Cancer J; 2022 Jul; 12(7):106. PubMed ID: 35803921
[TBL] [Abstract][Full Text] [Related]
3. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
4. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.
Kanagal-Shamanna R; Luthra R; Yin CC; Patel KP; Takahashi K; Lu X; Lee J; Zhao C; Stingo F; Zuo Z; Routbort MJ; Singh RR; Fox P; Ravandi F; Garcia-Manero G; Medeiros LJ; Bueso-Ramos CE
Oncotarget; 2016 Mar; 7(12):14251-8. PubMed ID: 26883102
[TBL] [Abstract][Full Text] [Related]
5. Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.
Montes-Moreno S; Routbort MJ; Lohman EJ; Barkoh BA; Kanagal-Shamanna R; Bueso-Ramos CE; Singh RR; Medeiros LJ; Luthra R; Patel KP
PLoS One; 2018; 13(9):e0204218. PubMed ID: 30222780
[TBL] [Abstract][Full Text] [Related]
6. Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.
Coombs CC; Gillis NK; Tan X; Berg JS; Ball M; Balasis ME; Montgomery ND; Bolton KL; Parker JS; Mesa TE; Yoder SJ; Hayward MC; Patel NM; Richards KL; Walko CM; Knepper TC; Soper JT; Weiss J; Grilley-Olson JE; Kim WY; Earp HS; Levine RL; Papaemmanuil E; Zehir A; Hayes DN; Padron E
Clin Cancer Res; 2018 Dec; 24(23):5918-5924. PubMed ID: 29866652
[TBL] [Abstract][Full Text] [Related]
7. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA
J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
Soverini S; De Benedittis C; Polakova KM; Linhartova J; Castagnetti F; Gugliotta G; Papayannidis C; Mancini M; Klamova H; Salvucci M; Crugnola M; Iurlo A; Albano F; Russo D; Rosti G; Cavo M; Baccarani M; Martinelli G
Oncotarget; 2016 Apr; 7(16):21982-90. PubMed ID: 26980736
[TBL] [Abstract][Full Text] [Related]
10. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
[TBL] [Abstract][Full Text] [Related]
11. TP53 and therapy-related myeloid neoplasms.
Chung J; Sallman DA; Padron E
Best Pract Res Clin Haematol; 2019 Mar; 32(1):98-103. PubMed ID: 30927980
[TBL] [Abstract][Full Text] [Related]
12. Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Voso MT; Pandzic T; Falconi G; Denčić-Fekete M; De Bellis E; Scarfo L; Ljungström V; Iskas M; Del Poeta G; Ranghetti P; Laidou S; Cristiano A; Plevova K; Imbergamo S; Engvall M; Zucchetto A; Salvetti C; Mauro FR; Stavroyianni N; Cavelier L; Ghia P; Stamatopoulos K; Fabiani E; Baliakas P
Br J Haematol; 2022 Jul; 198(1):103-113. PubMed ID: 35277855
[TBL] [Abstract][Full Text] [Related]
13. What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.
Voso MT; Falconi G; Fabiani E
Blood; 2021 Sep; 138(9):749-757. PubMed ID: 33876223
[TBL] [Abstract][Full Text] [Related]
14. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myeloid neoplasm with bone marrow involvement, myelosarcoma, and a t(8;16)(p11.2;p13.3)-a case report.
Chakraborty S; Adams J; Nassiri M; Vance GH
Cancer Genet; 2014; 207(10-12):511-5. PubMed ID: 25487769
[TBL] [Abstract][Full Text] [Related]
16. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.
Patel AA; Rojek AE; Drazer MW; Weiner H; Godley LA; Le Beau MM; Larson RA
Blood Adv; 2021 Oct; 5(20):4140-4148. PubMed ID: 34492705
[TBL] [Abstract][Full Text] [Related]
18. Mutations and prognosis in primary myelofibrosis.
Vannucchi AM; Lasho TL; Guglielmelli P; Biamonte F; Pardanani A; Pereira A; Finke C; Score J; Gangat N; Mannarelli C; Ketterling RP; Rotunno G; Knudson RA; Susini MC; Laborde RR; Spolverini A; Pancrazzi A; Pieri L; Manfredini R; Tagliafico E; Zini R; Jones A; Zoi K; Reiter A; Duncombe A; Pietra D; Rumi E; Cervantes F; Barosi G; Cazzola M; Cross NC; Tefferi A
Leukemia; 2013 Sep; 27(9):1861-9. PubMed ID: 23619563
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Clonal Hematopoiesis in Tumor-Infiltrating Leukocytes in Breast Cancer and Secondary Hematologic Malignancies.
Comen EA; Bowman RL; Selenica P; Kleppe M; Farnoud NR; Pareja F; Weigelt B; Hill CE; Alon A; Geyer FC; Akturk G; Reis-Filho JS; Norton L; Levine RL
J Natl Cancer Inst; 2020 Jan; 112(1):107-110. PubMed ID: 31504684
[TBL] [Abstract][Full Text] [Related]
20. Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant.
Tang G; Goswami RS; Liang CS; Bueso-Ramos CE; Hu S; DiNardo C; Medeiros LJ
Am J Clin Pathol; 2015 Jul; 144(1):78-86. PubMed ID: 26071464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
